A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels

NCT00271557 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
305
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Scios, Inc.